BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World J Gastroenterol 2019; 25(45): 6579-6606 [PMID: 31832000 DOI: 10.3748/wjg.v25.i45.6579]
URL: https://www.wjgnet.com/1007-9327/full/v25/i45/6579.htm
Number Citing Articles
1
Julián David Martínez-Marín, Sandra Consuelo Henao-Riveros, Martín Alonso Garzón-Olarte. Hepatopatías autoinmunes. Hallazgos clínicos y de laboratorio en pacientes de un hospital de referencia nacionalHepatología 2021; : 355 doi: 10.52784/27112330.140
2
Hauke Thomsen, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki, Gianfranco D. Alpini. Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseasesPLOS ONE 2020; 15(10): e0240794 doi: 10.1371/journal.pone.0240794
3
Taiba Jibril Afaa, Kokou Hefoume Amegan-Aho, Matilda Tierenye Dono, Eric Odei, Yaw Asante Awuku, Nikhil Pai. Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan AfricaPLOS ONE 2020; 15(12): e0239964 doi: 10.1371/journal.pone.0239964
4
Albert J Czaja. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver diseaseWorld Journal of Gastroenterology 2021; 27(25): 3705-3733 doi: 10.3748/wjg.v27.i25.3705
5
Nikolaos K. Gatselis, Kalliopi Azariadis, Aggeliki Lyberopoulou, George N. Dalekos. Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitisJournal of Translational Autoimmunity 2021; 4: 100126 doi: 10.1016/j.jtauto.2021.100126
6
Weronika Domerecka, Anna Kowalska-Kępczyńska, Agata Michalak, Iwona Homa-Mlak, Radosław Mlak, Halina Cichoż-Lach, Teresa Małecka-Massalska. Etiopathogenesis and Diagnostic Strategies in Autoimmune HepatitisDiagnostics 2021; 11(8): 1418 doi: 10.3390/diagnostics11081418
7
Akihiro Yamaguchi, Toshiaki Teratani, Po‐sung Chu, Takahiro Suzuki, Nobuhito Taniki, Yohei Mikami, Shunsuke Shiba, Rei Morikawa, Takeru Amiya, Ryo Aoki, Takanori Kanai, Nobuhiro Nakamoto. Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented MiceHepatology Communications 2021; 5(9): 1555 doi: 10.1002/hep4.1742
8
Albert J. Czaja. Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune HepatitisDigestive Diseases and Sciences 2021; 66(8): 2493 doi: 10.1007/s10620-020-06562-2
9
Albert J. Czaja. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune HepatitisDigestive Diseases and Sciences 2021;  doi: 10.1007/s10620-021-06968-6
10
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver DiseasesFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196